Article

Pharmacy Tied to Meningitis Outbreak Files for Bankruptcy

The New England Compounding Center, the compounding pharmacy that produced the tainted drugs that killed 39 people and injured more than 600 others, filed for bankruptcy Friday.

The Framingham, Mass., company shut its doors in October after public health officials traced a nationwide outbreak of meningitis to the firm's shipments of tainted vials of methylprednisolone acetate, an injectable drug prescribed by some pain physicians for back ailments.

Read the full story: http://bit.ly/Tjweno

Source: ModernHealthcare.com

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Mehmet Oz, MD, MBA
Hira Ghani, DO, discusses underdiagnosed skin conditions in children
Nicole Bajic, MD
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
2 experts in this video
Related Content
Child standing on scale | Image credit: Protsenko Dmitriy - stock.adobe.com
July 26th 2025

How to Utilize a Multimodal Treatment Approach for Childhood Obesity

Pearl Steinzor
With obesity rates rising sharply, the American Academy of Pediatrics calls for multimodal strategies to address the crisis in youth.
managed care cast logo
July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
anaphylaxis training. | Image Credit: Flex_Point_Security - stock.adobe.com
July 25th 2025

AllergyAware E-Learning Training Program Boosts Anaphylaxis Preparedness in School Staff

Cameron Santoro
The AllergyAware e-learning course effectively trained school personnel on anaphylaxis management, significantly improving their knowledge and confidence in using epinephrine auto-injectors, despite some technical and pacing issues reported by users.
Managed Care Cast
Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Headshots of Robyn Guo Ku, BS, a medical student; Tarannum Jaleel, MD, MS; and Daniela Kroshinsky, MD, MPH | Background image credit: ipopba - stock.adobe.com
July 25th 2025

Navigating Pediatric Hidradenitis Suppurativa: A Q&A on Early Diagnosis and Effective Treatment

Laura Joszt, MA Robyn Guo Ku Tarannum Jaleel, MD, MS Daniela Kroshinsky, MD, MPH
Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared with infliximab in children.
Topical cream for AD | Image credit: Ladanifer - stock.adobe.com
July 25th 2025

Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD

Pearl Steinzor
A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo